Skip to main content

A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma TRYbeCA-1 ¿ TRial of erYaspase in pancreatic CAncer

Clinical Trial Grant
Duke Scholars

Awarded By

ERYTECH Pharma

Start Date

October 29, 2019

End Date

July 31, 2023
 

Awarded By

ERYTECH Pharma

Start Date

October 29, 2019

End Date

July 31, 2023